Cohance Lifesciences Limited (COHANCE.NS) — Financial ratios
Profitability, liquidity, leverage, and valuation ratios for Cohance Lifesciences Limited, with annual and quarterly history.
| Metric | 2026 |
|---|---|
| Valuation | |
| P/E Ratio | 64.28x |
| P/B Ratio | 2.95x |
| P/S Ratio | 5.08x |
| Profitability | |
| Gross Margin | 40.2% |
| Operating Margin | 10.6% |
| Net Margin | 7.9% |
| EBITDA Margin | 19.0% |
| Liquidity | |
| Current Ratio | 2.78x |
| Quick Ratio | 1.91x |
| Leverage | |
| Debt/Equity | 0.10x |
YoY = year-over-year change. Source: FMP..